Cesar D Vera-Donoso
Overview
Explore the profile of Cesar D Vera-Donoso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
74
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oto J, Herranz R, Verger P, Roca M, Plana E, Miralles M, et al.
J Proteomics
. 2024 Nov;
311:105357.
PMID: 39561853
Renal cell carcinoma (RCC) stands among the most lethal urological malignancies. Most RCCs are incidentally diagnosed as initial symptoms are unspecific. Novel, minimally-invasive diagnostic and prognostic methods for RCC are...
2.
Herranz R, Oto J, Hueso M, Plana E, Cana F, Castano M, et al.
Front Immunol
. 2023 Jun;
14:1171065.
PMID: 37275882
Background: Neutrophils, key players of the immune system, also promote tumor development through the formation of neutrophil extracellular traps (NETs) in a process called NETosis. NETs are extracellular networks of...
3.
Perez-Ardavin J, Martinez-Sarmiento M, Monserrat-Monfort J, Vera-Pinto V, Sopena-Novales P, Bello-Arques P, et al.
Q J Nucl Med Mol Imaging
. 2022 Jun;
67(4):287-293.
PMID: 35762662
Background: The objective was to carry out a prospective study to compare the current extended pelvic lymph node dissection (ePLND) to the sentinel node (SN) technique with Tcnanocolloid. Methods: We...
4.
Garcia-Dominguez X, Vera-Donoso C, Lopez-Moncholi E, Moreno-Manzano V, Vicente J, Marco-Jimenez F
J Clin Med
. 2022 Jun;
11(11).
PMID: 35683456
In order to harness the potential of metanephroi allotransplantation to the generation of a functional kidney graft on demand, we must achieve further growth post-transplantation. Sildenafil citrate (SC) is widely...
5.
Herranz R, Oto J, Plana E, Fernandez-Pardo A, Cana F, Martinez-Sarmiento M, et al.
Cancers (Basel)
. 2021 Apr;
13(6).
PMID: 33810039
Bladder cancer (BC) is among the most frequent cancer types in the world and is the most lethal urological malignancy. Presently, diagnostic and follow-up methods for BC are expensive and...
6.
Oto J, Plana E, Fernandez-Pardo A, Cana F, Martinez-Sarmiento M, Vera-Donoso C, et al.
Biomedicines
. 2020 Oct;
8(11).
PMID: 33105660
Bladder cancer (BC) is among the most frequent malignancies worldwide, being the most expensive cancer to treat and monitor and the most lethal urological cancer. Urine microRNAs (miRNAs) have been...
7.
Canizares G, Gonzalez-Montoro A, Freire M, Lamprou E, Barrio J, Sanchez F, et al.
EJNMMI Phys
. 2020 Jun;
7(1):38.
PMID: 32504230
Background: Prostate cancer (PCa) represents one of the most common types of cancers facing the male population. Nowadays, to confirm PCa, systematic or multiparametric MRI-targeted transrectal or transperineal biopsies of...
8.
Oto J, Plana E, Sanchez-Gonzalez J, Garcia-Olaverri J, Fernandez-Pardo A, Espana F, et al.
Curr Urol Rep
. 2020 Mar;
21(2):11.
PMID: 32166474
Purpose Of Review: Renal cell carcinoma (RCC) is the third most common urologic malignancy. First symptoms are usually unspecific and belated causing the stages to be high when diagnosed. As...
9.
Oto J, Fernandez-Pardo A, Roca M, Plana E, Solmoirago M, Sanchez-Gonzalez J, et al.
J Proteomics
. 2020 Mar;
218:103723.
PMID: 32126320
Renal cell carcinoma (RCC) is one of the most lethal type of tumors and is twice more frequent in men than in women. Initial symptoms are unspecific and belated thus...
10.
Oto J, Fernandez-Pardo A, Royo M, Hervas D, Martos L, Vera-Donoso C, et al.
Sci Rep
. 2020 Feb;
10(1):2463.
PMID: 32051423
The diagnostic specificity of prostate specific antigen (PSA) is limited. We aimed to characterize eight anti-PSA monoclonal antibodies (mAbs) to assess the prostate cancer (PCa) diagnostic utility of different PSA...